RESEARCH REPORTS
1035 -- Cardiovascular Morbidity Associated with Nonadherence to Statin Therapy
David F. Blackburn, Pharm.D., Roy T. Dobson, Ph.D., James L. Blackburn, Pharm.D., and Thomas W. Wilson, M.D.
1044 -- Acute Pancreatitis Associated with Different Combination Therapies in Patients Infected with Human Immunodeficiency Virus
Jeff J. Guo, Ph.D., Raymond Jang, Ph.D., Anthony Louder, B.S., and Robert J. Cluxton, Pharm.D.
1055 -- Warfarin Monitoring in Ambulatory Older Individuals Receiving Antimicrobial Therapy
Marsha A. Raebel, Pharm.D., Daniel M. Witt, Pharm.D., Nikki M. Carroll, M.S., and David J. Magid, M.D., M.P.H.
1062 -- Effect of Access to Anticoagulation Management Services on Warfarin Use in Patients with Atrial Fibrillation
Jill S. Burkiewicz, Pharm.D.
BRIEF REPORTS
1068 -- Elevated Plasma Concentrations of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis B or C: Case Series and Literature Review
Sarah M. Robertson, Pharm.D., Kimberly K. Scarsi, Pharm.D., Michael J. Postelnick, B.S., and Patrick Lynch, M.D.
1073 -- Experience with an Adult Alcohol Withdrawal Syndrome Practice Guideline in Internal Medicine Patients
Karen M. Stanley, M.S., Cathy L. Worrall, Pharm.D., FAPhA, Shayna L. Lunsford, M.S., Kit N. Simpson, Dr.P.H., Justin G. Miller, M.D., and Anne P. Spencer, Pharm.D.
REVIEWS OF THERAPEUTICS
1084 -- Ziconotide, an Intrathecally Administered N-Type Calcium Channel Antagonist for the Treatment of Chronic Pain
Daniel P. Wermeling, Pharm.D.
1095 -- N-acetylcysteine for Prevention of Radiographic Contrast MaterialÐInduced Nephropathy: Is the Intravenous Route Best?
Stephen J. Shalansky, Pharm.D., FCSHP, Thanh Vu, Pharm.D., Gordon E. Pate, M.B., M.Sc., Adeera Levin, M.D., Karin H. Humphries, M.B.A., D.Sc., and John G. Webb, M.D.
1104 -- Ketamine for Conscious Sedation in Pediatric Emergency Care
Rakhee B. Mistry and Milap C. Nahata, Pharm.D.
MINIREVIEWS
1112 -- Duration of Treatment of Deep Vein Thrombosis: Time for a New Approach?
Paula G. Rychlik, Pharm.D., Karol S. Henry, Pharm.D., and Henry I. Bussey, Pharm.D., FCCP
1116 -- Expert Clinical Decision Support Systems to Enhance Antimicrobial Stewardship Programs
Insights from the Society of Infectious Diseases Pharmacists
Stanley L. Pestotnik, M.S.
1126 -- Aldosterone Receptor Antagonism in Heart Failure
Douglas L. Jennings, Pharm.D., James S. Kalus, Pharm.D., and Kate M. OÕDell, Pharm.D.
CASE REPORTS
1134 -- Treatment of Acute Myeloid Leukemia During the Second and Third Trimesters of Pregnancy
Dawn M. Niedermeier, Pharm.D., Debra A. Frei-Lahr, M.D., and Philip D. Hall, Pharm.D., FCCP
1141 -- Central Serous Chorioretinopathy After Epidural Steroid Injection
Joseph J. Pizzimenti, O.D., and Karen P. Daniel, Pharm.D.
1147 -- Challenge and Rechallenge: Drotrecogin alfa (activated)ÐInduced Prolongation of Activated Partial Thromboplastin Time in a Patient with Severe Sepsis
Emily E. Castelli, Pharm.D., Colleen M. Culley, Pharm.D., and Mitchell P. Fink, M.D., FCCM
1151 -- Delayed-Onset Grade 4 Neutropenia Associated with Rituximab Therapy in a Patient with Lymphoma: Case Report and Literature Review
Susannah E. Motl, Pharm.D., and Reed C. Baskin, M.D.
1156 -- Zotepine-Induced Catatonia as a Precursor in the Progression to Neuroleptic Malignant Syndrome
Jui-Hsiu Tsai, M.D., Pinchen Yang, M.D., Ju-Yu Yen, M.D., Cheng-Chung Chen, M.D., Ph.D., and Ming-Jen Yang, M.D., Sc.D.